Ad Alert

Saffron USA

Unauthorized health claims come down in wake of FDA warning letter.

Saffron USA, a Florida-based business that claims to import Persian saffron, has wiped a number of unauthorized health claims for its products from its website in response to a recent FDA warning letter.

Among the products that the FDA found Saffron USA marketing with Only FDA-approved drugs can be marketed as having the ability to diagnose, cure, treat, prevent or mitigate a disease., which TINA.org confirmed have since been removed: an “allergy blend” whose touted health benefits had included “asthma,” a “diabetic support blend” that was also marketed to treat cancer, and a saffron loose tea blend that the company had claimed “fights anxiety” and helps with insomnia.

Remember, readers, marketing anything other than FDA-approved drugs as having the ability to treat, cure, alleviate the symptoms of, or prevent developing diseases and disorders is simply not permitted by law.

Find more of our coverage on illegal disease-treatment claims here.


Our Ad Alerts are not just about false and deceptive marketing issues, but may also be about ads that, although not necessarily deceptive, should be viewed with caution. Ad Alerts can also be about single issues and may not include a comprehensive list of all marketing issues relating to the brand discussed.


You Might Be Interested In

UNBS CBD Gummies

Ad Alert

UNBS CBD Gummies

Spam email leads to a fake endorsement from Dr. Oz, among other celebrities.